Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PharmaMar has announced today the signing of a commercialization and distribution license agreement with Pint Pharma International for the marine-derived anticancer drug Aplidin.
read more
PharmaMar announced the signing of an agreement with Impilo Pharma, a part of Immedica Group, for the exclusive promotion and distribution of its antitumour compound, Yondelis.
read more
Wednesday, February 14, 2018
Seattle Genetics has received exclusive worldwide rights to certain PharmaMar proprietary molecules for the development, manufacture and commercialization of ADCs.
read more
It is my pleasure to announce to you that Pharmalucence has been acquired by Sun Pharmaceuticals
(www.sunpharma.com), a world leader in the development and marketing of generic drugs.
read more
Friday, December 13, 2013
Pharmalucence, Inc. (www.pharmalucence.com) today announced that it has entered into an agreement with Lantheus Medical Imaging, Inc. (www.lantheus.com) to serve as a contract manufacturer of DEFINITY® Vial for (Perflutren Lipid Microsphere) ...
read more
Wednesday, April 09, 2025
PharmaLogic Holdings Corp. will acquire a majority stake in Agilera Pharma AS from the Institute for Energy Technology (IFE) in Norway, marking a significant step forward in the company's strategy to create the first fully-integrated, global CDMO ...
read more
PharmaLogic Holdings Corp., a contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, announced the opeing of its radiopharmaceutical production and research facility in the Bronx, New York.
read more
Thursday, October 31, 2024
PharmaLogic Holdings Corp. announced the official opening of its radiopharmaceutical production and research facility in Los Angeles, California.
read more
PharmaLogic announced the opening of its new PET radiopharmaceutical manufacturing facility in Atlanta, Georgia.
read more
PharmaLogic Holdings Corp. announced the company has appointed Etienne Montagut, currently serving as President, to the position of President and Chief Executive Officer, effective as of 1 June 2025.
read more
Monday, December 30, 2019
PharmaLink announced that it started Phase 1 of its expansion project in response to new contracts and increased demand for its reverse distribution services.
read more
PharmaLex Group has announced a merger with UK pharmaceutical and healthcare services consultancy, NeoHealthHub Limited.
read more
Thursday, October 14, 2021
PharmaLex Group has announced the formal launch of a major new service line, Biopharma Excellence, and the appointment of ex-MHRA scientific lead Dr. Christian K. Schneider as head of the new unit and as its Chief Medical Officer.
read more
Wednesday, August 17, 2022
PharmaLex Group will merge with the Finnish consulting company, DRA Consulting. DRA Consulting becomes part of the broader PharmaLex Nordic region post-merger.
read more
Wednesday, February 09, 2022
PharmaLex Group has announced a merger agreement with Ascent Development Services.
Founded in 2017, Ascent’s team of experts work with emerging biopharma companies to understand and overcome differences in medical practice, culture and language in ...
read more